Literature DB >> 26060310

Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.

Yayi Gao1, Jiayou Tang2, Weiqian Chen3, Qiang Li3, Jia Nie4, Fang Lin4, Qingsi Wu5, Zuojia Chen4, Zhimei Gao4, Huimin Fan6, Andy Tsun4, Jijia Shen5, Guihua Chen7, Zhongmin Liu6, Zhenkun Lou8, Nancy J Olsen3, Song Guo Zheng9, Bin Li10.   

Abstract

Forkhead box P3 (FOXP3)-positive Treg cells are crucial for maintaining immune homeostasis. FOXP3 cooperates with its binding partners to elicit Treg cells' signature and function, but the molecular mechanisms underlying the modulation of the FOXP3 complex remain unclear. Here we report that Deleted in breast cancer 1 (DBC1) is a key subunit of the FOXP3 complex. We found that DBC1 interacts physically with FOXP3, and depletion of DBC1 attenuates FOXP3 degradation in inflammatory conditions. Treg cells from Dbc1-deficient mice were more resistant to inflammation-mediated abrogation of Foxp3 expression and function and delayed the onset and severity of experimental autoimmune encephalomyelitis and colitis in mice. These findings establish a previously unidentified mechanism regulating FOXP3 stability during inflammation and reveal a pathway for potential therapeutic modulation and intervention in inflammatory diseases.

Entities:  

Keywords:  Deleted in breast cancer 1; FOXP3 complex; inflammation; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26060310      PMCID: PMC4485127          DOI: 10.1073/pnas.1421463112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.

Authors:  Qin Lan; Xiaohui Zhou; Huimin Fan; Maogen Chen; Julie Wang; Bernhard Ryffel; David Brand; Rajalakshmy Ramalingam; Pawel R Kiela; David A Horwitz; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2012-07-06       Impact factor: 6.216

3.  TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway.

Authors:  Qi Zhang; Feifei Cui; Lei Fang; Jian Hong; Biao Zheng; Jingwu Z Zhang
Journal:  J Mol Cell Biol       Date:  2012-12-12       Impact factor: 6.216

Review 4.  Development and maintenance of regulatory T cells.

Authors:  Naganari Ohkura; Yohko Kitagawa; Shimon Sakaguchi
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.

Authors:  Zhiyuan Li; Fang Lin; Changhua Zhuo; Guoping Deng; Zuojia Chen; Shuying Yin; Zhimei Gao; Miranda Piccioni; Andy Tsun; Sanjun Cai; Song Guo Zheng; Yu Zhang; Bin Li
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

7.  Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions.

Authors:  Ling Lu; Qin Lan; Zhiyuan Li; Xiaohui Zhou; Jian Gu; Qiang Li; Julie Wang; Maogen Chen; Ya Liu; Yi Shen; David D Brand; Bernhard Ryffel; David A Horwitz; Francisco P Quismorio; Zhongmin Liu; Bin Li; Nancy J Olsen; Song Guo Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-06       Impact factor: 11.205

8.  Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.

Authors:  Jianguang Du; Chunjian Huang; Baohua Zhou; Steven F Ziegler
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3.

Authors:  Zuojia Chen; Joseph Barbi; Shurui Bu; Huang-Yu Yang; Zhiyuan Li; Yayi Gao; Dilini Jinasena; Juan Fu; Fang Lin; Chen Chen; Jing Zhang; Ning Yu; Xiangpei Li; Zhao Shan; Jia Nie; Zhimei Gao; Hong Tian; Yangyang Li; Zhengju Yao; Ying Zheng; Benjamin V Park; Ziyi Pan; Jing Zhang; Eric Dang; Zhiguang Li; Honglin Wang; Weibo Luo; Liwu Li; Gregg L Semenza; Song-Guo Zheng; Karin Loser; Andy Tsun; Mark I Greene; Drew M Pardoll; Fan Pan; Bin Li
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

10.  A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells.

Authors:  Wenxian Fu; Ayla Ergun; Ting Lu; Jonathan A Hill; Sokol Haxhinasto; Marlys S Fassett; Roi Gazit; Stanley Adoro; Laurie Glimcher; Susan Chan; Philippe Kastner; Derrick Rossi; James J Collins; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more
  56 in total

1.  A Novel Prognostic Score Combining Preoperative Biliary Drainage and Inflammatory Status for Patients with Periampullary Cancers.

Authors:  Yuki Fujiwara; Koichiro Haruki; Ryoga Hamura; Takashi Horiuchi; Yoshihiro Shirai; Kenei Furukawa; Takeshi Gocho; Hiroaki Shiba; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

Review 2.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

3.  Thymus-derived Foxp3+ regulatory T cells upregulate RORγt expression under inflammatory conditions.

Authors:  Juhao Yang; Mangge Zou; Joern Pezoldt; Xuyu Zhou; Jochen Huehn
Journal:  J Mol Med (Berl)       Date:  2018-10-24       Impact factor: 4.599

Review 4.  Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis.

Authors:  Ximei Zhang; Feng Huang; Yanming Chen; Xiaoxian Qian; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  A protocol to develop T helper and Treg cells in vivo.

Authors:  Weiqian Chen; Zhenjian Xu; Yongjiang Zheng; Julie Wang; Wenbin Qian; Nancy Olsen; David Brand; Jin Lin; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

Review 6.  The effect of icariin on immunity and its potential application.

Authors:  Rong Shen; Ju-Hua Wang
Journal:  Am J Clin Exp Immunol       Date:  2018-06-05

7.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

8.  Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction.

Authors:  Shok Ping Lim; Benedetta Costantini; Syed A Mian; Pilar Perez Abellan; Shreyans Gandhi; Marc Martinez Llordella; Juan Jose Lozano; Rita Antunes Dos Reis; Giovanni A M Povoleri; Thanos P Mourikis; Ander Abarrategi; Linda Ariza-McNaughton; Susanne Heck; Jonathan M Irish; Giovanna Lombardi; Judith C W Marsh; Dominique Bonnet; Shahram Kordasti; Ghulam J Mufti
Journal:  Blood       Date:  2020-08-13       Impact factor: 22.113

Review 9.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

Review 10.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.